Adams Diversified Equity Fund, Inc. Halozyme Therapeutics, Inc. Transaction History

Adams Diversified Equity Fund, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 26, 2019	SELL	$13.94 - $17.58 $372,198 - $469,385	-26,700 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$13.33 - $18.66 $15,996 - $22,392	-1,200 Reduced 4.3%	26,700 $391,000
Q3 2018 Oct 29, 2018	SELL	$16.68 - $18.41 $33,360 - $36,820	-2,000 Reduced 6.69%	27,900 $507,000
Q2 2018 Jul 26, 2018	SELL	$16.87 - $20.3 $42,175 - $50,750	-2,500 Reduced 7.72%	29,900 $504,000
Q1 2018 Apr 27, 2018	BUY	$17.06 - $21.2 $552,744 - $686,880	32,400 New	32,400 $635,000

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Adams Diversified Equity Fund, Inc., based on Form 13F filings with the SEC.

Stay updated on Adams Diversified Equity Fund, Inc. with notifications on news.